Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-16

Marsh & Mclennan Companies, Inc. (MRSH) Stock Forecast Oct. 16, 2026

Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE

Follow Unlock full AI forecasts
Rating · 90D ▼ Bearish Exact rating locked
90-day forecast Sign up free to reveal
30-day forecast Alpha
Rank in coverage Bottom 35% of 5171 stocks scored
Rank correlation · 90D -19.0% Spearman, 357 dates
Market Cap $89.88B large-cap · #1 of 23 peers
Summary

Marsh & Mclennan Companies, Inc. (MRSH) stock forecast summary

Our AI ranks Marsh & Mclennan Companies, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

Marsh & Mclennan Companies, Inc. is a large-cap company with a market capitalization of $89.88B. It ranks number 1 by market capitalization among the 23 Insurance Agents, Brokers & Service issuers in our coverage with a current forecast.

For MRSH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -19.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -2.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, MRSH included.

Follow MRSH free
Price

MRSH price chart and AI forecast

MRSH
Cross-section · 2026-10-16

How MRSH ranks among 5171 stocks

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals · 2026-09-30

Marsh & Mclennan Companies, Inc. (MRSH) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Insurance Agents, Brokers & Service peers listed below that report each metric.

Valuation & Market

MetricMRSHIndustry medianRank
Market Cap $89.88B $4.03B 1/23
P/E Ratio 22.53x 30.53x 8/12
P/B Ratio 6.12x 4.91x 8/18
Dividend Yield 2.00% 1.98% 4/9
EPS $8.36 – –
Book Value/Share $30.75 – –
Revenue/Share $59.64 – –
FCF/Share $8.70 – –

Profitability & Margins

MetricMRSHIndustry medianRank
ROE 27.5% 25.0% 5/12
ROA 6.8% 2.2% 5/14
ROIC 16.1% 16.1% 6/11
Operating Margin 21.4% 19.8% 7/14
Net Margin 14.2% 10.0% 5/15
EBT Margin 18.9% 13.9% 9/22
Tax Rate 23.2% – –

Financial Health

MetricMRSHIndustry medianRank
Current Ratio 1.09x 1.16x 12/20
D/E Ratio 3.06x 1.83x 7/20
Financial Leverage 4.08x 3.15x 5/16
Interest Coverage 1.4x 2.5x 12/19
Working Capital $2.00B $48M 2/20

Cash Flow

MetricMRSHIndustry medianRank
Operating Cash Flow $4.47B $93M 1/24
Free Cash Flow $4.15B $114M 1/13
Capital Spending -$320M -$37M 13/13
OCF Growth YoY -12.1% 4.5% 12/14
FCF Growth YoY -13.9% 12.5% 9/9
FCF/Sales 14.6% 14.6% 7/13
CapEx/Sales 1.1% 1.1% 7/13

Operational Efficiency

MetricMRSHIndustry medianRank
Asset Turnover 0.48x 0.67x 10/17
Receivables Turnover 3.3x 8.7x 11/13
Fixed Assets Turnover 34.9x 48.0x 9/14
Days Sales Outstanding 110 days 42 days 3/13

Income Statement

MetricMRSHIndustry medianRank
Total Revenue $28.46B $1.31B 1/22
Operating Income $6.09B $64M 1/16
Net Income $4.04B $54M 1/17

Dividend & Shareholder Information

MetricMRSHIndustry medianRank
Dividends Per Share $3.77 – –
Payout Ratio 45.1% 20.8% 1/5
Shares Outstanding 477M – –
Net Income Growth -2.1% 0.9% 11/13
EPS Growth 0.4% 4.4% 6/10

Balance Sheet Highlights (USD millions)

Total Current Assets$24.11B40.3% of assets
Cash & Short-term Investments$1.84B3.1% of assets
Accounts Receivable$8.55B14.3% of assets
Total Liabilities$44.90B75.1% of assets
Quarterly Financial Reports

MRSH quarterly financials and insider trading

Industry Peers · Insurance Agents, Brokers & Service

Marsh & Mclennan Companies, Inc. (MRSH) industry peers

Companies classified under the same SEC industry code as Marsh & Mclennan Companies, Inc. (Insurance Agents, Brokers & Service): 26 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Alpha) Market Cap P/E Ratio P/B Ratio
MRSH Marsh & Mclennan Companies, Inc. ▼ $89.88B 22.5x 6.1x
AJG Arthur J. Gallagher & Co. ▼ $65.33B 42.3x 2.8x
AON Aon Plc ▼ $62.06B 16.1x 13.0x
BRO Brown & Brown, Inc. ▼ $23.22B 22.2x 1.9x
EQH Equitable Holdings, Inc. ▼ $14.53B – –
ERIE Erie Indemnity Co ▶ $11.26B 19.5x 9.0x
RYAN Ryan Specialty Holdings, Inc. ▶ $10.42B 105.3x 20.5x
ACT Enact Holdings, Inc. ▲ $6.28B 9.6x 1.2x
HGTY Hagerty, Inc. ▶ $5.26B 206.5x 24.4x
BWIN Baldwin Insurance Group, Inc. ▼ $4.45B – 5.0x
ARX Accelerant Holdings ▼ $4.29B – 12.4x
NP Neptune Insurance Holdings Inc. ▶ $4.03B – –
CRVL Corvel Corp ▶ $4.03B 35.4x 9.9x
GSHD Goosehead Insurance, Inc. ▲ $1.66B 36.5x –
TWFG Twfg, Inc. ▲ $1.35B 43.1x 29.3x
CRD-A Crawford & Co ▲ $603M 25.6x 4.8x
RDZN Roadzen Inc. ▲ $88M – –
SLQT Selectquote, Inc. ▲ $60M – 0.2x
HIT Health In Tech, Inc. ▲ $41M – 2.1x
EHTH Ehealth, Inc. ▲ $19M – –
HUIZ Huize Holding Ltd ▶ $14M – 1.3x
CCG Cheche Group Inc. ▲ $12M – 0.2x
EZRA Reliance Global Group, Inc. ▶ $2M – 0.4x
AAPI Apple Isports Group, Inc. ▼ N/A – –
QDMI Qdm International Inc. ▼ N/A – –
SUND Sundance Strategies, Inc. ▶ N/A – –

Where MRSH sits on the market map

Finance · Insurance Agents, Brokers & Service
Explore the map →
News

Marsh & Mclennan Companies, Inc. (MRSH) stock news

Loading...

FAQ

Marsh & Mclennan Companies, Inc. (MRSH) stock forecast FAQ

What is the Marsh & Mclennan Companies, Inc. (MRSH) stock forecast?

Our AI ranks Marsh & Mclennan Companies, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

How accurate are Marsh & Mclennan Companies, Inc. stock predictions?

For MRSH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -19.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -2.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Marsh & Mclennan Companies, Inc. forecasts updated?

Marsh & Mclennan Companies, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.

Which companies are Marsh & Mclennan Companies, Inc.'s industry peers?

26 issuers in our coverage, MRSH included, share the SEC industry code Insurance Agents, Brokers & Service. The largest are: Arthur J. Gallagher & Co. (AJG), Aon Plc (AON), Brown & Brown, Inc. (BRO), Equitable Holdings, Inc. (EQH), Erie Indemnity Co (ERIE), Ryan Specialty Holdings, Inc. (RYAN).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.